Brought to you by 
CANbridge gains its second cancer project through deal with EUSA
20 Jul 2015
Executive Summary
CANbridge Life Sciences Ltd. gained its second cancer project, licensing exclusive rights to sell in China EUSA Pharma's Caphosol oral rinse.
Deal Industry
- Biotechnology
- Medical Devices
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com